Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 11:33 PM
NCT ID:
NCT05631093
Pre Assignment Details:
Of the 553 participants randomly assigned in a 2:1 ratio to either Group 1: participants switched from baseline ART to doravirine (DOR)/islatravir (ISL) on Day 1 to Week 144; or Group 2: participants continued baseline ART until Week 48 then switch to DOR/ISL from Week 48 to Week 144, 551 participants received treatment.
Recruitment Details:
Adults living with human immunodeficiency virus-1 (HIV-1) receiving baseline antiretroviral therapy (ART) were enrolled.
Study:
NCT05631093
Study Brief:
Results Section:
NCT05631093